Literature reviews

To download literature reviews on Neutropenia, click on the following articles:


2011

Evaluation of the Patient-Generated Subjective Global Assessment (PG-SGA) as a predictor of febrile neutropenia in gynecologic cancer patients receiving combination chemotherapy: a pilot study [154 KB]
Phippen NT, et al. Gynecol Oncol. 2011; 123(2):360-4
The importance of G-CSF prophylaxis in R-CHOP-14 therapy for diffuse large B-cell lymphoma in routine clinical practice [155 KB]
Johnsen HE, et al. Leukemia & Lymphoma 2011; [doi:10.3109/10428194.2011.643407] [Epub ahead of print]
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis [151 KB]
Cooper KL, Madan J, et al. BMC Cancer 2011; [doi:10.1186/1471-2407-11-404] [Epub ahead of print]
Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network [154 KB]
Hui EP, Leung LKS, et al. Support Care Cancer 2011; 19:1625-35
Effect of Primary Prophylactic Granulocyte Colony-Stimulating Factor Use on Incidence of Neutropenia Hospitalizations for Elderly Early-Stage Breast Cancer Patients Receiving Chemotherapy [158 KB]
Rajan SS, Lyman GH, et al. Medical Care 2011; 49(7):649-57
Predicting Individual Risk of Neutropenic Complications in Patients Receiving Cancer Chemotherapy [152 KB]
Lyman GH, Kuderer NM, et al. Cancer 2011; 117(9):1917-27
Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study [151 KB]
Tan H, Tomic K, et al. Curr Med Res Opin 2011; 27(1):79-86
A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings [155 KB]
Okera M, Chan S, et al. Br J Cancer 2011; 104(3):407-12
Last update: 2012-02-28

The content of this website is intended for healthcare professionals.
All content is approved by the INC-EU study group members.

The INC-EU and this website are supported by an educational grant from

Amgen (Europe) GmbH.